+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Infection Surveillance Solutions Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • July 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855124
The global infection surveillance solutions market value was USD 536.9 million in 2022, driven by the increasing growing awareness and focus on patient safety and infection prevention across the globe. The market size is anticipated to grow at a CAGR of 13.82% during the forecast period of 2023-2031 to achieve a value of USD 1747.5 million by 2031.

Infection Surveillance Solutions: Introduction

Infection surveillance solutions play a crucial role in the prevention and control of healthcare-associated infections (HAIs) in healthcare facilities. These solutions utilize advanced technologies and software applications to track and analyze data related to infections, helping healthcare organizations identify and respond to potential outbreaks and implement effective infection control measures.

The introduction of infection surveillance solutions has transformed the way healthcare facilities monitor and manage infections. Traditional methods of surveillance, such as manual reporting and paper-based records, are being replaced by automated systems that streamline the process and provide real-time monitoring capabilities. These solutions enable healthcare providers to identify trends, monitor infection rates, and take proactive measures to prevent the spread of infections.

Key Trends in the Global Infection Surveillance Solutions Market

In terms of market trends, the adoption of infection surveillance solutions is expected to grow significantly due to the increasing focus on patient safety, infection prevention, and regulatory compliance. The COVID-19 pandemic has further highlighted the importance of effective infection control measures, leading to a greater demand for advanced surveillance solutions.

Additionally, the integration of artificial intelligence (AI) and machine learning (ML) technologies into infection surveillance solutions is a key trend in the market. These technologies enhance the accuracy and efficiency of data analysis, enabling faster and more precise identification of infection patterns and trends. The use of predictive analytics and real-time alerts further enhances the proactive nature of infection surveillance.

Overall, infection surveillance solutions are vital tools for healthcare facilities in their efforts to prevent and control HAIs. The market is driven by the increasing need for advanced infection control measures, regulatory compliance, and the integration of AI and ML technologies. As healthcare organizations continue to prioritize patient safety and infection prevention, the demand for innovative and effective infection surveillance solutions is expected to grow.

Global Infection Surveillance Solutions Market Segmentations

Market Breakup by Product and Services

Product

  • Software
  • Web/Cloud Based
  • On-premises Based

Services

  • Product Support and Maintenance Services
  • Training and Consulting Services
  • Implementation Services
  • Other Services

Market Breakup by Infection Type

  • Surgical Site Infection
  • Urinary Tract Infection
  • Blood Stream Infection
  • Others

Market Breakup by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Long-term Care Facilities
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Infection Surveillance Solutions Market Scenario

The market for infection surveillance solutions is experiencing significant growth due to the increasing emphasis on infection prevention and control in healthcare facilities. Infection surveillance solutions are advanced software applications that enable healthcare organizations to monitor, analyze, and manage data related to healthcare-associated infections (HAIs). These solutions play a crucial role in helping healthcare facilities detect, track, and respond to potential outbreaks, ultimately improving patient safety and reducing the spread of infections.

The market introduction of infection surveillance solutions has transformed the way healthcare facilities approach infection control. Traditional manual methods of surveillance, such as paper-based reporting and manual data collection, are being replaced by automated systems that offer real-time monitoring, data integration, and advanced analytics capabilities. This shift has resulted in improved accuracy, efficiency, and timeliness in identifying and managing infections.

The market for infection surveillance solutions is driven by several factors. Firstly, there is a growing awareness and focus on patient safety and infection prevention among healthcare providers and regulatory bodies. The need to comply with stringent infection control guidelines and regulatory requirements is pushing healthcare facilities to adopt advanced surveillance solutions.

Secondly, the rising incidence of HAIs and the associated healthcare costs are driving the demand for effective infection surveillance solutions. Healthcare organizations are increasingly investing in technologies that can help them proactively identify and respond to infections, reducing the burden on healthcare systems and improving patient outcomes.

Furthermore, advancements in data analytics, artificial intelligence (AI), and machine learning (ML) technologies are revolutionizing the field of infection surveillance. These technologies enable the analysis of large volumes of data, identification of patterns and trends, and generation of real-time alerts and predictive insights. The integration of AI and ML in infection surveillance solutions enhances the accuracy and speed of data analysis, facilitating early detection and intervention.

Global Infection Surveillance Solutions Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Becton, Dickinson and Company
  • Baxter International Inc
  • Wolters Kluwer NV
  • Premier Inc
  • Gojo Industries
  • BioVigil Healthcare Systems Inc
  • Medexter Healthcare GmbH
  • Koninklijke Philips NV
  • PeraHealth
  • Deb Group Ltd
  • Cerner Corporation
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Infection Surveillance Solutions Market Overview
3.1 Global Infection Surveillance Solutions Market Historical Value (2016-2022)
3.2 Global Infection Surveillance Solutions Market Forecast Value (2023-2031)
4 Global Infection Surveillance Solutions Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Infection Surveillance Solutions Market Segmentation
5.1 Global Infection Surveillance Solutions Market by Product and Services
5.1.1 Market Overview
5.1.2 Product
5.1.2.1 Software
5.1.2.1.1 Web/Cloud Based
5.1.2.1.2 On-premises Based
5.1.3 Services
5.1.3.1 Product Support and Maintenance Services
5.1.3.2 Training and Consulting Services
5.1.3.3 Implementation Services
5.1.3.4 Other Services
5.2 Global Infection Surveillance Solutions Market by Infection Type
5.2.1 Market Overview
5.2.2 Surgical Site Infection
5.2.3 Urinary Tract Infection
5.2.4 Blood Stream Infection
5.2.5 Others
5.3 Global Infection Surveillance Solutions Market by End User
5.3.1 Market Overview
5.3.2 Hospitals and Clinics
5.3.3 Ambulatory Surgical Centers
5.3.4 Specialty Centers
5.3.5 Long-term Care Facilities
5.3.6 Others
5.4 Global Infection Surveillance Solutions Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Infection Surveillance Solutions Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Infection Surveillance Solutions Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Infection Surveillance Solutions Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Infection Surveillance Solutions Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Infection Surveillance Solutions Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Becton, Dickinson and Company
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 Baxter International Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 Wolters Kluwer NV
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 Premier Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 Gojo Industries
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 BioVigil Healthcare Systems Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 Medexter Healthcare GmbH
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 Koninklijke Philips NV
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 PeraHealth
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 Deb Group Ltd.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
16.11 Cerner Corporation
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisition
16.11.5 Certifications
17 Global Infection Surveillance Solutions Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Wolters Kluwer NV
  • Premier Inc.
  • Gojo Industries
  • BioVigil Healthcare Systems Inc.
  • Medexter Healthcare GmbH
  • Koninklijke Philips NV
  • PeraHealth
  • Deb Group Ltd.
  • Cerner Corporation

Methodology

Loading
LOADING...

Table Information